Prognostic value of myocardial perfusion imaging in asymptomatic high-risk diabetic patients: 10-year follow-up of the prospective multicentre BARDOT trial
A normal SPECT was associated with an excellent long-term prognosis in high-risk T2DM patients. Hence, SPECT could serve as a valuable tool for advanced risk stratification in this population.
Authors
- Raban Jeger (ORCID: https://orcid.org/0000-0003-1290-5491)
- Damian Wild (ORCID: https://orcid.org/0000-0002-8135-5350)
- Kathrin Thommen
- Miriam Brinkert (ORCID: https://orcid.org/0000-0001-6571-0423)
- Ulrich Bernd Keller (ORCID: https://orcid.org/0000-0002-8485-1958)
- Felix Mahfoud (ORCID: https://orcid.org/0000-0002-4425-549X)
- Jan Müller‐Brand
- Otmar Pfister (ORCID: https://orcid.org/0000-0002-6155-5494)
- Gianluca Haenny
- Philip Haaf (ORCID: https://orcid.org/0000-0002-5657-6637)
- Simon Frey (ORCID: https://orcid.org/0000-0002-6786-7931)
- Daniel Kämmerer
- Federico Caobelli (ORCID: https://orcid.org/0000-0003-2472-775X)
- Michael J. Zellweger (ORCID: https://orcid.org/0000-0001-7825-0470)
- Stefanie von Felten (ORCID: https://orcid.org/0000-0002-5264-6394)
- Thilo Burkard (ORCID: https://orcid.org/0000-0001-6373-9820)
- Matthias Pfisterer
- Hans H. Osterhues
- Michael Mauraun
- Naina Rastalksy
Institutions
- Anaheim University (US)
- University of Basel (CH)
- University Hospital of Basel (CH)
- Cardiovascular Institute Hospital (JP)
- Hospital Base (CL)
Publication Details
- Journal
- European Heart Journal - Cardiovascular Imaging
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1093/ehjci/jeaf126
- Citations
- 2
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.72
Funders
- Pfizer
- Foundation for Cardiovascular Research
- Schweizerische Herzstiftung